Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19

We presented the clinical course and immune responses of a well-controlled HIV-positive patient with COVID-19. The clinical presentation and antibody production to SARS-CoV-2 were similar to other COVID-19 patients without HIV infection. Neutralizing antibody reached a plateau from 26th to 47th day...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wang-Da, Hung, Chien-Ching, Wang, Jann-Tay, Tsai, Ming-Jui, Kuo, Po-Hsien, Chao, Tai-Ling, Hsieh, Szu-Min, Sheng, Wang-Huei, Chen, Yee-Chun, Chang, Sui-Yuan, Chang, Shan-Chwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Formosan Medical Association. Published by Elsevier Taiwan LLC. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059939/
https://www.ncbi.nlm.nih.gov/pubmed/33933336
http://dx.doi.org/10.1016/j.jfma.2021.04.010
_version_ 1783681269375172608
author Liu, Wang-Da
Hung, Chien-Ching
Wang, Jann-Tay
Tsai, Ming-Jui
Kuo, Po-Hsien
Chao, Tai-Ling
Hsieh, Szu-Min
Sheng, Wang-Huei
Chen, Yee-Chun
Chang, Sui-Yuan
Chang, Shan-Chwen
author_facet Liu, Wang-Da
Hung, Chien-Ching
Wang, Jann-Tay
Tsai, Ming-Jui
Kuo, Po-Hsien
Chao, Tai-Ling
Hsieh, Szu-Min
Sheng, Wang-Huei
Chen, Yee-Chun
Chang, Sui-Yuan
Chang, Shan-Chwen
author_sort Liu, Wang-Da
collection PubMed
description We presented the clinical course and immune responses of a well-controlled HIV-positive patient with COVID-19. The clinical presentation and antibody production to SARS-CoV-2 were similar to other COVID-19 patients without HIV infection. Neutralizing antibody reached a plateau from 26th to 47th day onset but decreased on 157th day after symptoms.
format Online
Article
Text
id pubmed-8059939
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Formosan Medical Association. Published by Elsevier Taiwan LLC.
record_format MEDLINE/PubMed
spelling pubmed-80599392021-04-22 Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19 Liu, Wang-Da Hung, Chien-Ching Wang, Jann-Tay Tsai, Ming-Jui Kuo, Po-Hsien Chao, Tai-Ling Hsieh, Szu-Min Sheng, Wang-Huei Chen, Yee-Chun Chang, Sui-Yuan Chang, Shan-Chwen J Formos Med Assoc Case Report We presented the clinical course and immune responses of a well-controlled HIV-positive patient with COVID-19. The clinical presentation and antibody production to SARS-CoV-2 were similar to other COVID-19 patients without HIV infection. Neutralizing antibody reached a plateau from 26th to 47th day onset but decreased on 157th day after symptoms. Formosan Medical Association. Published by Elsevier Taiwan LLC. 2021-12 2021-04-21 /pmc/articles/PMC8059939/ /pubmed/33933336 http://dx.doi.org/10.1016/j.jfma.2021.04.010 Text en © 2021 Formosan Medical Association. Published by Elsevier Taiwan LLC. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Case Report
Liu, Wang-Da
Hung, Chien-Ching
Wang, Jann-Tay
Tsai, Ming-Jui
Kuo, Po-Hsien
Chao, Tai-Ling
Hsieh, Szu-Min
Sheng, Wang-Huei
Chen, Yee-Chun
Chang, Sui-Yuan
Chang, Shan-Chwen
Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19
title Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19
title_full Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19
title_fullStr Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19
title_full_unstemmed Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19
title_short Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19
title_sort evolution of sars-cov-2 neutralizing antibody in an hiv-positive patient with covid-19
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059939/
https://www.ncbi.nlm.nih.gov/pubmed/33933336
http://dx.doi.org/10.1016/j.jfma.2021.04.010
work_keys_str_mv AT liuwangda evolutionofsarscov2neutralizingantibodyinanhivpositivepatientwithcovid19
AT hungchienching evolutionofsarscov2neutralizingantibodyinanhivpositivepatientwithcovid19
AT wangjanntay evolutionofsarscov2neutralizingantibodyinanhivpositivepatientwithcovid19
AT tsaimingjui evolutionofsarscov2neutralizingantibodyinanhivpositivepatientwithcovid19
AT kuopohsien evolutionofsarscov2neutralizingantibodyinanhivpositivepatientwithcovid19
AT chaotailing evolutionofsarscov2neutralizingantibodyinanhivpositivepatientwithcovid19
AT hsiehszumin evolutionofsarscov2neutralizingantibodyinanhivpositivepatientwithcovid19
AT shengwanghuei evolutionofsarscov2neutralizingantibodyinanhivpositivepatientwithcovid19
AT chenyeechun evolutionofsarscov2neutralizingantibodyinanhivpositivepatientwithcovid19
AT changsuiyuan evolutionofsarscov2neutralizingantibodyinanhivpositivepatientwithcovid19
AT changshanchwen evolutionofsarscov2neutralizingantibodyinanhivpositivepatientwithcovid19

Ejemplares similares